Latest research results on Johnson & Johnson (JNJ.US) CAR-T therapy announced

Johnson & Johnson (JNJ.US) recently announced the latest research results of the phase 3 clinical trial CARTITUDE-4.

Zhitong FinanceDec 12 08:03

Johnson & Johnson to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

Businesswire05:30

Jim Cramer Says This CEO 'Built An Amazing Company,' Recommends Buying Netflix

BenzingaDec 12 21:55

U.S. FDA Expands Indication for Impella Heart Pumps to Treat Pediatric Patients

PR NewswireDec 12 21:30

Today's Analyst Rating | Citi Cuts Its Price Target Cut on Johnson & Johnson to $175, Deutsche Bank Upgrades Coca-Cola to Buy

Dec 12, Wall Street analysts have updated their stock ratings today including $Johnson & Johnson(JNJ.US)$ and $Coca-Cola(KO.US)$.

Futu NewsDec 12 21:00 · Ratings

Bank of America resumes coverage of Johnson & Johnson with a Target Price of $166.

Gelonghui, December 12 | Bank of America: Resumes coverage of Johnson & Johnson, giving it a "neutral" rating, with a Target Price of $166. (Gelonghui)

Gelonghui FinanceDec 12 16:16 · Ratings